Pathophysiology and Progression to Heart Failure

Slide 1 · Pathophysiology and

Progression to Heart Failure

From compensatory remodeling to myocardial dysfunction

Mechanisms • structural adaptation • decompensation • clinicopathologic correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain why increased cardiac work induces myocyte hypertrophy and ventricular remodeling.

Distinguish pressure-overload and volume-overload patterns at the sarcomere and organ levels.

Trace ischemia, fibrosis, and molecular reprogramming toward systolic or diastolic failure.

Differentiate physiologic exercise hypertrophy from persistent pathologic hypertrophy.

Slide 3 · Heart failure is the endpoint of failed compensation

Hemodynamic stress or injury

Compensation preserves flow

Chronic remodeling

Functional decompensation

Structural adaptation is initially useful, not intrinsically synonymous with failure.

Persistence of the initiating stress can make the adaptive response harmful.

Slide 4 · Heart failure: A functional definition

The heart cannot meet peripheral metabolic demands, or can do so only at elevated filling pressures.

Reduced forward flow and elevated filling pressures are distinct, often coexisting problems.

Anatomical enlargement alone does not establish heart failure.

Slide 5 · Chronic stress and acute insults converge on failure

Chronic routes

Acute precipitants

Hypertension → persistent pressure work

Myocardial infarction → abrupt loss of contractile mass

Valve disease → sustained pressure or volume load

Abrupt valvular dysfunction

Ischemic heart disease → cumulative injury

Acute fluid overload

A failing circulation may emerge gradually or deteriorate abruptly.

Slide 6 · Six cardiac pathophysiologic mechanisms

Pump failure

Impaired contraction or relaxation

Flow obstruction

Pressure load from stenosis or hypertension

Regurgitant flow

Volume burden from backward flow

Shunted flow

Inappropriate chamber/vessel flow

Conduction disorder

Ineffective coordinated pumping

Rupture

Loss of circulatory continuity

Pressure and volume loading are especially important routes into compensatory hypertrophy.

Slide 7 · The compensation–decompensation distinction

Initially adaptive

Ultimately harmful if sustained

Augmented contraction and perfusion

Persistent metabolic demand

Salt/water conservation to support filling

Congestion and elevated filling pressure

Greater ventricular muscle mass

Supply–demand mismatch and fibrosis

Remodeling to accommodate load

Loss of contractile or filling reserve

The same response can change its effect over time.

Slide 8 · Two functional dimensions of cardiac failure

Systolic dysfunction

Impaired ventricular emptying

Lower ejection fraction

Diastolic dysfunction

Impaired ventricular relaxation/filling

Elevated pressure despite preserved EF

These are physiological emphases, not completely separate diseases.

Slide 9 · Ejection fraction describes ventricular emptying

LVEF (%) = [(EDV − ESV) / EDV] × 100

EDV: End-diastolic volume; ESV: End-systolic volume. EF is not a direct measure of perfusion.

Textbook healthy reference: Approximately 50%–70%.

A reduced value supports systolic dysfunction; Preserved EF does not exclude failure.

Slide 10 · Textbook categories: Reduced versus preserved EF

HFrEF

HFpEF

LVEF ≤40%

LVEF ≥50%

Systolic dysfunction predominates

Diastolic dysfunction predominates

Ventricular emptying is impaired

Ventricular filling may require high pressure

Often linked to damage or dilation

Often linked to stiff, hypertrophied myocardium

The source section does not define the intermediate-EF category; No additional cutoff is implied.

Slide 11 · Forward failure and backward failure

Forward consequence

Reduced cardiac output

↓ Tissue perfusion

Backward consequence

Venous blood pools upstream

Pulmonary or systemic edema

Both patterns may be present at different intensities in the same patient.

Slide 12 · Ventricular remodeling is more than enlargement

Molecular, cellular, and structural alterations following injury or altered ventricular loading.

Includes changes in myocyte size, chamber geometry, gene expression, and extracellular matrix.

May initially preserve function but gradually reduce reserve.

Slide 13 · Three coordinated compensatory mechanisms

Increased cardiac work or impaired pump function

Frank–Starling recruitment

Neurohumoral activation

Myocardial hypertrophy/remodeling

These responses support arterial pressure and tissue perfusion when work rises.

They are limited in duration and may become contributors to progression.

Slide 14 · Frank–Starling compensation: Filling recruits force

Greater filling volume

Myocyte stretch

More effective actin–myosin interaction

Stronger systolic contraction

Immediate adaptation uses existing myocardium rather than new muscle mass.

Increased filling also raises the burden on a ventricle with limited reserve.

Slide 15 · Frank–Starling reserve does not prevent progression

More filling volume can initially strengthen systolic contraction.

Structural remodeling may eventually compromise both contraction and relaxation.

At decompensation, high filling pressures can coexist with inadequate output.

The reserve mechanism explains compensation, not permanent correction of an injured heart.

Slide 16 · Adrenergic activation: Immediate circulatory support

Autonomic norepinephrine release

Increased heart rate

Increased contractility

Increased vascular resistance

These effects may initially maintain arterial pressure.

Persistently increased heart rate and inotropy also increase oxygen consumption.

Slide 17 · The adrenergic tradeoff

Short-term benefit

↑ Heart rate

↑ Contractile force

Long-term burden

↑ Metabolic requirement

Additional wall-work demand

β-adrenergic signals among trophic stimuli for myocyte hypertrophy.

Slide 18 · RAAS activation expands circulating volume

Renin–angiotensin–aldosterone activation

Salt + water retention

More circulating volume

Enhanced filling

RAAS also raises vascular tone.

Expansion of volume can worsen congestion once filling capacity is limited.

Slide 19 · RAAS compensation can increase backward pressure

Compromised circulation

Fluid retention

High venous/filling pressure

Pulmonary or systemic edema

Volume conservation aids perfusion early in disease.

Continued retention aggravates congestion in decompensated heart failure.

Slide 20 · Atrial natriuretic peptide is counter-regulatory

RAAS response

Salt/water conservation

Increased vascular tone

Atrial natriuretic peptide

Promotes diuresis

Relaxes vascular smooth muscle

Competing neurohumoral responses regulate volume and pressure; Balance may still fail.

Slide 21 · Neurohumoral activation is a balancing system

Circulatory

Compensation

Adrenergic drive

Rate / inotropy / resistance

RAAS

Retention / vascular tone

Natriuretic response

Diuresis / relaxation

A systems response is useful acutely, but cannot eliminate ongoing myocardial injury.

Slide 22 · Mechanical work activates myocyte growth

Pressure or volume overload

Mechanical work + cell stretch

Increased protein synthesis

Cardiomyocyte hypertrophy

Trophic signals, including β-adrenergic activation, may also initiate growth.

Organ enlargement accumulates from growth of individual cardiac myocytes.

Slide 23 · Cardiac hypertrophy is cellular enlargement

Greater myocyte size cumulatively increases cardiac mass and weight.

The adaptive response requires synthesis of additional contractile proteins.

Adult myocytes commonly respond by hypertrophy rather than a proportional rise in cell number.

Slide 24 · New contractile machinery requires protein synthesis

Sustained growth stimulus

More sarcomeric proteins

Additional sarcomeres

Greater myocyte dimensions

The spatial arrangement of new sarcomeres determines the pattern of remodeling.

Mitochondrial numbers also increase as the cell enlarges.

Slide 25 · Mitochondria increase in hypertrophied cells

Cardiac myocyte growth entails more than accumulation of contractile filaments.

Additional mitochondria support the needs of an enlarged contractile cell.

Despite greater cellular machinery, oxygen delivery may fail to scale with mass.

This mismatch helps explain why marked hypertrophy can coexist with functional vulnerability.

Slide 26 · Hypertrophic nuclei may enlarge or multiply

Baseline myocyte

Hypertrophied myocyte (schematic)

Enlarged or multiple nuclei may accompany myocyte hypertrophy.

DNA replication without cell division increases nuclear DNA ploidy.

Microscopic nuclear enlargement is not, by itself, evidence of malignancy.

Schematic — not histologic microscopy

Slide 27 · Pressure overload principally thickens myocardium

Hypertension / aortic stenosis

Increased ventricular pressure work

Parallel sarcomere addition

Concentric wall thickening

The myocyte gains cross-sectional area.

A characteristic response is increased wall thickness.

Slide 28 · Parallel sarcomeres expand cell width

Baseline arrangement

Parallel addition

New sarcomeres align predominantly beside existing sarcomeres.

The resulting larger cell cross-section contributes to concentric hypertrophy.

Slide 29 · Pressure overload: Concentric ventricular geometry

Original schematic ventricular cross-sections — not clinical images

Baseline

Pressure overload

The ventricle accommodates sustained high pressure by increasing muscle thickness.

Wall geometry alone does not establish preserved ventricular function.

Slide 30 · Common pressure-overload settings

Systemic hypertension

Sustained systemic pressure burden

Aortic stenosis

Increased outflow resistance

Cardiac work

Higher load on ventricular myocytes

Typical response

Predominantly concentric hypertrophy

The cause and chamber loading must be identified, not inferred from wall thickness alone.

Slide 31 · Volume overload chiefly dilates the chamber

Valvular regurgitation

Higher ventricular volume work

Sarcomeres added in series

Predominant chamber dilation

The cell expands primarily along its long axis.

In the enlarged chamber, wall thickness can be variable.

Slide 32 · Series sarcomeres increase myocyte length

Baseline arrangement

Series addition

Additional sarcomeres are arranged end-to-end with existing units.

Myocyte lengthening contributes to ventricular dilation.

Slide 33 · Volume overload: A dilated ventricular chamber

Original schematic ventricular cross-sections — not clinical images

Baseline

Volume overload

Regurgitant loading favors increased cavity size.

Cardiac mass can increase even if the wall does not appear thick.

Slide 34 · Wall thickness is unreliable in a dilated heart

Why a dilated heart may look thin

What better captures hypertrophy

The chamber circumference is enlarged

Heart weight reflects overall muscle mass

Thickness can increase, remain normal, or decrease

Thickness alone can understate growth

Dilation can follow previous pressure hypertrophy

Interpret weight with chamber dimensions

Robbins explicitly favors heart weight over wall thickness in dilated hearts.

Slide 35 · Pressure and volume overload: Side-by-side

Pressure overload

Volume overload

Hypertension; Aortic stenosis

Valvular regurgitation

Parallel sarcomere addition

Series sarcomere addition

Myocyte cross-sectional growth

Myocyte longitudinal growth

Concentric wall thickening

Predominant ventricular dilation

Wall thickness often rises

Wall thickness may be variable

Both routes can produce increased heart mass and eventual dysfunction.

Slide 36 · The heart can be both hypertrophied and dilated

Original schematic ventricular cross-sections — not clinical images

Baseline

Concentric

Hypertrophy + dilation

An initially thick-walled ventricle may dilate with progressive failure.

The dilated hypertrophied ventricle can appear deceptively normal in wall thickness.

Slide 37 · Cardiac weight may rise strikingly

Systemic hypertension, ischemic heart disease, aortic stenosis, mitral regurgitation, and dilated cardiomyopathy can produce markedly increased heart weight.

Hearts weighing about two to three times the average in several of these conditions.

Aortic regurgitation or hypertrophic cardiomyopathy can sometimes yield three- to fourfold increases.

These are descriptive source examples, not clinical diagnostic thresholds.

Slide 38 · Myocardial infarction creates a regional workload shift

Myocardial infarction

Loss of functioning muscle

More work borne by viable myocardium

Compensatory hypertrophy

Remodeling in the surviving myocardium occurs around a regional injury.

The distribution of overload differs from globally stressed ventricles.

Slide 39 · Valvular disease imposes more global loading

Post-infarction remodeling

Valvular remodeling

Regional loss of myocardial mass

Pressure/volume load on much of the chamber

Surviving cells carry extra work

Myocardium responds to shared loading

Viable myocardium hypertrophies

Global hypertrophy/dilation can occur

The pathologic trigger determines which regions first experience altered work.

Slide 40 · Myocardial growth outpaces microvascular support

Schematic: Myocyte growth without proportional capillary expansion

Smaller myocytes

Hypertrophied myocytes

Myocyte enlargement is not matched by proportional capillary-density growth.

Relative oxygen and nutrient delivery becomes less secure.

The mismatch is particularly consequential in pressure-overloaded myocardium.

Slide 41 · Hypertrophy creates an oxygen supply–demand mismatch

Supply pressure

Relative capillary scarcity

Less robust nutrient delivery

Demand pressure

Greater muscle mass

Increased oxygen consumption

The enlarged heart becomes more vulnerable to ischemia-related decompensation.

Slide 42 · Why myocardial oxygen demand increases

Mass

More hypertrophied tissue

Heart rate

Faster repetitive contractions

Inotropy

Greater force generation

Consequence

Higher myocardial oxygen use

Supply does not necessarily expand proportionally as these demands increase.

Slide 43 · Pressure-overloaded myocardium is ischemia-prone

Concentric hypertrophy

Limited relative perfusion reserve

Greater oxygen requirement

Ischemic vulnerability

Ischemia can compromise function even without new gross enlargement.

A chronically adapted ventricle may cross from compensation into failure.

Slide 44 · Mechanical stress activates fibroblasts as well

Sustained mechanical forces

Myocardial fibroblast activation

More extracellular matrix synthesis

Interstitial fibrosis

Fibrosis is a parallel response to the same loading stimulus that drives myocyte growth.

Myocytes and stromal cells jointly determine the remodeled myocardium.

Slide 45 · Interstitial fibrosis resists diastolic filling

Fibrous matrix deposition

Stiffer ventricular wall

Greater resistance to filling

Higher filling pressure

Interstitial fibrosis can worsen function without an obvious fall in EF.

This is a key connection between morphology and diastolic failure.

Slide 46 · Myocyte hypertrophy and fibrosis act together

Myocyte component

Larger contractile cells

Greater oxygen demand

Stromal component

More interstitial matrix

Less compliant myocardium

The failing heart is not explained by myocyte size in isolation.

Slide 47 · Anatomic abnormality does not equal dysfunction severity

Some heavy and dilated hearts show substantial functional failure.

Other hearts can have comparatively modest visible abnormalities yet serious filling or contractile defects.

Macroscopic inspection does not reveal all structural, biochemical, or molecular determinants of performance.

Assessment requires physiological as well as morphologic interpretation.

Slide 48 · The failing heart may be heavy, dilated, or thin-walled

Original schematic ventricular cross-sections — not clinical images

Earlier compensated

Dilated failing ventricle

Congestive failure generally involves heavy, often dilated hearts.

Wall thickness may be relatively low despite greater cardiac mass.

Histologic hypertrophy varies with the etiology and stage.

Slide 49 · Microscopic remodeling: What to seek

Myocytes: Little interstitial matrix

Expanded extracellular matrix

Larger myocytes, often with enlarged nuclei.

Interstitial fibrous tissue between myocytes.

Neither feature alone quantifies the degree of functional failure.

Schematic — not histologic microscopy

Slide 50 · Early-response genes participate in myocyte growth

FOS

JUN

MYC

EGR1

Immediate-early transcriptional response

Cellular growth and altered protein expression

Hypertrophied cardiomyocytes express immediate-early genes.

These transcriptional responses support growth and altered protein expression.

Slide 51 · Prolonged overload reactivates fetal programs

Chronic hemodynamic overload

Altered cardiomyocyte gene program

Fetal-form protein expression

Changed myocardial phenotype

Examples include fetal forms of myosin, natriuretic peptides, and collagen.

Molecular remodeling can be present even when gross appearance is non-specific.

Slide 52 · Remodeling involves multiple myocardial cell states

Cardiomyocytes

Contractile-cell enlargement and gene changes

Fibroblasts

Extracellular matrix synthesis

Microvascular compartment

Capillary supply fails to scale

Integrated myocardium

Emergent systolic/diastolic function

Single-cell analyses are resolving cell-type and cell-state changes.

Slide 53 · Progression pathway: Stress to dysfunction

Mechanical load

Hypertrophy / dilation

Supply mismatch + fibrosis

Systolic / diastolic dysfunction

Initially adaptive responses may become maladaptive with sustained loading

Persistent pathologic work may overwhelm compensation; This conceptual sequence is not a fixed timetable.

Slide 54 · Systolic failure: A contractile pathway

Ischemic injury / impaired adaptation

Reduced effective contraction

Less ventricular emptying

Lower ejection fraction

Ventricular dilation may accompany the process.

LVEF reflects emptying but does not explain the entire remodeling mechanism.

Slide 55 · Diastolic failure: A filling pathway

Hypertrophy + fibrosis

Abnormal relaxation/compliance

Inadequate diastolic filling

Elevated filling pressure

Failure can occur despite preserved ejection fraction.

Mechanical resistance to filling links tissue change to clinical congestion.

Slide 56 · Different mechanisms, shared clinical consequences

Systolic pathway

Diastolic pathway

Impaired contraction

Impaired relaxation/filling

Reduced ejection fraction often evident

Ejection fraction may remain preserved

Output may fall

Output reserve may be inadequate

High filling pressure can develop

High filling pressure can develop

Forward and backward consequences are possible in either pattern.

Slide 57 · Pulmonary congestion translates filling pressure to symptoms

High left-sided filling pressure

Pulmonary venous congestion

Pulmonary interstitial/alveolar edema

Dyspnea

This is a downstream clinical consequence, not the primary remodeling mechanism.

Right-sided failure is covered separately in the adjoining unit.

Slide 58 · Physiologic hypertrophy is a different adaptation

Exercise-associated

Persistent disease-associated

Training stimulus

Pressure/volume overload or injury

Potentially beneficial adaptation

Progression to functional vulnerability

Aerobic training may raise capillary density

Capillary density does not rise proportionally

Resting rate and blood pressure may fall

Metabolic burden often increases

Shared enlargement does not imply the same biological consequences.

Slide 59 · Aerobic exercise favors adaptive volume-type remodeling

Regular aerobic training

Volume-type hypertrophy

Increased capillary density

Lower resting heart rate / pressure

Examples include endurance activities such as long-distance running.

Lower resting heart rate and blood pressure are noted in the source.

Slide 60 · Static exercise produces a different loading pattern

Static exertion / weightlifting

Repeated pressure stress

Mild pressure-type hypertrophy

Less beneficial remodeling pattern

The text gives recurrent Valsalva maneuvers as an example of the pressure stimulus.

Do not equate this with the severity or prognosis of pathologic hypertension.

Slide 61 · Clinicopathologic case: Long-standing hypertension

Teaching vignette (hypothetical)

An adult with chronic systemic hypertension develops a thick left ventricular wall and gradually increasing exertional limitation.

What cellular mechanism produces the typical wall geometry?

Parallel sarcomere addition increases myocyte cross-sectional area; Fibrosis may later impair filling.

Mechanism: Pressure overload

Expected remodeling: Concentric hypertrophy

Potential later deficit: Diastolic filling resistance

Slide 62 · Clinicopathologic case: Chronic valve regurgitation

Teaching vignette (hypothetical)

A patient with long-standing valvular regurgitation has marked cavity enlargement; The ventricular wall looks only modestly thick.

Does modest wall thickness exclude hypertrophy?

No. Series sarcomere addition and dilation can increase cardiac mass without conspicuously increasing wall thickness.

Mechanism: Volume overload

Expected remodeling: Cavity dilation

More useful morphologic metric: Overall cardiac mass

Slide 63 · Clinicopathologic case: Surviving myocardium after infarction

Teaching vignette (hypothetical)

Following myocardial infarction, a ventricle develops progressive enlargement with altered function.

Why would surviving cardiomyocytes enlarge?

Loss of functioning muscle shifts workload to viable myocardium, inducing compensatory hypertrophy.

Initiator: Regional myocardial loss

Adaptive response: Increased work in viable muscle

Longer-term risk: Decompensation

Slide 64 · Clinicopathologic case: Preserved EF, high filling pressure

Teaching vignette (hypothetical)

A hypertrophied, fibrotic ventricle has preserved ejection fraction yet fills poorly and develops pulmonary congestion.

Which failure dimension explains this presentation?

Diastolic dysfunction: A stiff ventricle may require elevated filling pressures despite preserved EF.

Myocardial substrate: Hypertrophy + interstitial fibrosis

Physiologic deficit: Low compliance

Clinical effect: Backward congestion

Slide 65 · Three pitfalls when interpreting the failing heart

Pitfall 1

Thick wall ≠ preserved function

Pitfall 2

Normal wall thickness ≠ normal mass

Pitfall 3

Preserved EF ≠ no failure

Correct approach

Integrate load, geometry, histology, and physiology

Macroscopic, cellular, and functional observations answer different questions.

Slide 66 · Integrated mechanism: From work to congestion

Persistent loading / injury

Hypertrophy + molecular changes

Fibrosis + ischemic vulnerability

Functional failure + congestion

Progression is not inevitable at a fixed time or cardiac weight.

Severity depends on the initiating insult and remaining myocardial reserve.

Slide 67 · Five distinctions to retain

Pressure overload: parallel sarcomeres; usually concentric wall thickening.

Volume overload: series sarcomeres; predominantly chamber dilation.

Hypertrophy increases demand without proportionately increasing capillary density.

Mechanical stress drives interstitial fibrosis and resistance to filling.

Molecular adaptation and gross anatomy do not reliably quantify functional reserve.